Adam D. Greenwood
Partner
Adam Greenwood is a partner practicing in the tax & benefits department. His practice focuses on transactional tax matters, including matters relating to private equity, real estate and hedge funds; mergers and acquisitions; inbound and outbound investments; and secondary transactions.
Experience
Fund Formation Matters
- Represents Benefit Street Partners in fund formation matters.
- Represents CCMP Capital in fund formation matters.
- Represents ACORE Capital in fund formation matters.
- Represents AlpInvest Partners in fund formation matters.
- Represents Metropolitan Real Estate in fund formation matters.
- Represents CIFC Asset Management in fund formation matters.
- Represents Angelo, Gordon & Co. in fund formation matters.
- Represents CI Capital Partners in fund formation matters.
- Represents KarpReilly Capital Partners in fund formation matters.
- Represents Western Asset Management Company in fund formation matters.
- Represents Capital Royalty Partners in fund formation and investment matters.
“Up-C” IPO Matters
- Represented TPG Growth in the reorganization and initial public offering (structured as an “up-C”) of Evolent Health, an information technology provider and consultancy firm in the healthcare sector.
- Represented TPG Growth in the registration and initial public offering (structured as an "up-C") of Greensky Inc., a financial technology company.
- Represented The Habit Restaurants, Inc., a hamburger restaurant chain, in its initial public offering (structured as an “up-C”).
- Represented Norcraft Companies, Inc., a cabinet maker, in its reorganization and initial public offering (structured as an “up-C”).
- Represented TPG Capital in the reorganization and initial public offering (structured as an “up-C”) of Taylor Morrison, a home builder.
M&A Matters
- Represented TPG Capital in its acquisition of a majority stake in McAfee, the cybersecurity company.
- Represented TPG Capital in its $3 billion acquisition of J. Crew, an apparel company.
- Represented Berkshire Partners in its $2 billion acquisition and combination of Lightower Fiber Networks and Sidera Networks.
- Represented HIG Capital in its acquisition of VIP Cinema Seating, a leading designer and assembler of premium seating solutions for the global cinema industry.
- Represents CCMP Capital in investment matters.
- Represented New Mountain Capital in its investment in Topix Pharmaceuticals, a leading provider of innovative therapeutic and cosmetic skin care products.
- Represented Bain Capital in its acquisition of a majority ownership stake in Canada Goose, a leading manufacturer of outerwear.
- Represented Johnson & Johnson in its acquisition of Aragon Pharmaceuticals, Inc. for $650 million upfront and up to $450 million in contingent payments.
- Represented TPG Capital and Petco Animal Supplies in connection with the sale of the latter.
- Represents KarpReilly in investment matters.
- Represents TPG Growth and its global impact fund, The Rise Fund, in investment matters.
- Represented Nypro, Inc., an employee-owned manufacturing company, in its $665 million sale to Jabil Circuit, Inc.
Publications
- Co-author, “Considerations When Purchasing Tax Receivable Agreements,” Law360 (July 27, 2018)
- Co-author, “Tax Receivable Agreements and Tax Reform Proposals,” Ropes & Gray Alert (November 10, 2017)
- Author, “Non-US investors and the lending trade-or-business debate,” Alt Credit Intelligence (August 2016)
- Author, “Non-US investors and the lending trade-or-business debate,” HFMWeek (August 4, 2016)
- Quoted, “Foreign Funds Slow To Buy US Property Despite Tax Change,” Law360 (July 22, 2016)
Presentations
- Panelist, “Impact of Tax Rules on Inbound and Outbound Investments by PE Funds,” Private Equity Tax Practices Conference (December 2018)
- Panelist, “Tax and Regulatory Update,” Private Debt Investor CFOs and COOs Forum 2018 (June 2018)
- Panelist, “Select Partnership Issues and Private Investment Funds,” American Bar Association (May 2016)
Education
- JD, New York University School of Law, 2006
- AB (Applied Mathematics and History), Brown University, 2003; Sigma Xi